Utilization of Biosimilars in Retinal Diseases - Episode 4

CHS-201 and Other Ranibizumab Biosimilars in Ophthalmology

August 1, 2022
Peter Kaiser, MD

Dr Peter Kaiser provides an overview of biosimilars that are either approved or are being developed for treatment of retinal diseases.

x